Indian Doxorubicin Exporters: Complete Supplier Ranking with Market Share — 899 Manufacturers (2026) — TransData Nexus

Q: Who is the largest doxorubicin buyer importing from India?

TARO PHARMACEUTICALS INC. (CANADA) is the largest doxorubicin importer from India with a 11.5% market share and import value of $7.7M.

Q: How many doxorubicin buyers import from India?

There are 899 active doxorubicin buyers importing from India, with a combined import market of $67.3M across 3,492 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top doxorubicin buyers from India?

The top 5 doxorubicin buyers — TARO PHARMACEUTICALS INC., DR REDDYS LABORATORIES,INC, SUN PHARMACEUTICAL INDUSTRIES,INC., SUN PHARMACEUTICAL INDUSTRIES INC, TARO PHARMACEUTICALS INC — together control 35.0% of total doxorubicin import value from India.

Suresh Sormare

Doxorubicin

India Pharmaceutical Trade Intelligence

$67.3M310 Suppliers136 CountriesHS 30049046

ExportsIndia → UNITED STATES39.4%India → CANADA18.9%

ImportsAUSTRALIA → India$16.6M BELGIUM → India$508.7K

#1 Supplier: SUN PHARMACEUTICAL #1 Buyer: TARO PHARMACEUTICALS

Market Analysis: Top Importing Countries & Their Importers

1United States

United States emerges as the first largest importing country, achieving a total trade value of $26.5M through 102 shipments. This represents a market share of 39.4% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: United States has a diverse importer base, with their top importers including:

• DR REDDYS LABORATORIES,INC - $7.0M (26.3% of country's total business)

• SUN PHARMACEUTICAL INDUSTRIES,INC. - $3.7M (14.0% of country's total business)

• SUN PHARMACEUTICAL INDUSTRIES INC - $2.7M (10.2% of country's total business)

• RXCROSSROADS 3PL LLC - $2.2M (8.2% of country's total business)

• SUN PHARMACEUTICAL INDUSTRIES INC., - $2.0M (7.5% of country's total business)

• Rest of United States's importers - $9.0M (33.8% of country's total business)

Key Insight: United States demonstrates strong market positioning with an average shipment value of $259.9K, indicating premium pricing strategy compared to the market average of $19.3K.

United States is a key market for Doxorubicin imports, representing 39.4% of total trade value.

Primary Market

Secondary Market

Buyer Segment Analysis

TransData Nexus Doxorubicin buyer market intelligence

1Buyer Segment Analysis

The buyer landscape for Doxorubicin imported from India encompasses several key segments:

1. Pharmaceutical Companies: Entities like TARO PHARMACEUTICALS INC. (Canada) and DR. REDDY'S LABORATORIES, INC. (United States) are prominent buyers. These companies procure Doxorubicin to manufacture and distribute under their brand names, ensuring a consistent supply to meet market demand. Their purchasing patterns typically involve large, regular orders to maintain inventory levels and fulfill contractual obligations.

2. Distributors: Organizations such as RXCROSSROADS 3PL LLC (United States) function as intermediaries, purchasing Doxorubicin in bulk and supplying it to healthcare providers, pharmacies, and hospitals. Distributors often place substantial orders to leverage economies of scale and ensure product availability across various regions.

3. Contract Manufacturers: Companies like SUN PHARMACEUTICAL INDUSTRIES, INC. (United States) and SUN PHARMA ANZ PTY LTD (Australia) may also act as contract manufacturers, producing Doxorubicin formulations for other pharmaceutical firms. Their procurement is driven by production schedules and client demands, leading to variable order sizes and frequencies.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Country-Specific Import Regulations

TransData Nexus Doxorubicin buyer market intelligence

1Country-Specific Import Regulations

United States

1. Regulatory Authority: U.S. Food and Drug Administration (FDA).

2. Import Registration Process: Importers must ensure that Doxorubicin is FDA-approved. This involves submitting a New Drug Application (NDA) or Abbreviated New Drug Application (ANDA) for generic versions.

3. Estimated Timeline for Registration: The FDA review process typically takes 10 months for standard applications, though priority reviews can be expedited to 6 months.

4. Import Tariff/Duty for HS 30049046: Pharmaceutical products under this HS code are generally duty-free in the United States.

Canada

1. Regulatory Authority: Health Canada.

2. Import Registration Process: Importers must obtain a Drug Identification Number (DIN) by submitting a New Drug Submission (NDS) or an Abbreviated New Drug Submission (ANDS) for generics.

3. Estimated Timeline for Registration: The review process can take up to 300 days for standard submissions.

4. Import Tariff/Duty for HS 30049046: Pharmaceutical products under this HS code are typically duty-free in Canada.

Mozambique

1. Regulatory Authority: Pharmacy Department of the Ministry of Health.

2. Import Registration Process: Importers must register pharmaceutical products by submitting a dossier that includes quality, safety, and efficacy data.

3. Estimated Timeline for Registration: The registration process can take approximately 12 months.

4. Import Tariff/Duty for HS 30049046: Pharmaceutical products may be subject to import duties; specific rates should be confirmed with local customs authorities.

Vietnam

1. Regulatory Authority: Drug Administration of Vietnam (DAV).

Demand Drivers & Market Opportunity

TransData Nexus Doxorubicin buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Doxorubicin in importing countries is primarily driven by the prevalence of cancers such as breast cancer, leukemia, and lymphomas, for which Doxorubicin is a standard chemotherapy agent. According to the World Health Organization (WHO), cancer remains a leading cause of morbidity and mortality worldwide, necessitating effective treatment options.

Government healthcare programs and the expansion of universal health coverage have also significantly influenced demand. Many countries have included Doxorubicin in their national essential medicines lists, aligning with the WHO Essential Medicines List, which recommends Doxorubicin for various cancers. Tender-based purchasing is common, especially in low- and middle-income countries, to procure medicines cost-effectively. The WHO suggests that countries use tendering for pharmaceutical products, considering factors such as product quality, availability, and supply security.

With 899 buyers across 136 countries, the global reach of Doxorubicin underscores its critical role in cancer treatment protocols and the ongoing efforts to make essential medicines accessible worldwide.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Common Questions — Doxorubicin Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest doxorubicin buyer importing from India?

Based on import volume and value, TARO PHARMACEUTICALS INC. (CANADA) leads with $7.7M in imports and a 11.5% market share — the highest of any single doxorubicin importer. DR REDDYS LABORATORIES,INC (UNITED STATES) and SUN PHARMACEUTICAL INDUSTRIES,INC. (UNITED STATES) are the next largest buyers.

QHow many companies buy doxorubicin from India?

There are 899 active doxorubicin buyers importing from India, with a combined market of $67.3M across 3,492 shipments to 136 countries. The top 5 buyers hold 35.0% of total import value, while the remaining 894 buyers handle the other 65.0%.

QWhich countries import the most doxorubicin from India?

The top importing countries for doxorubicin from India are United States (39.4%), Canada (18.9%), Mozambique (4.7%), Vietnam (4.4%), Saudi Arabia (3.2%). These markets represent the largest demand centres for Indian pharmaceutical exports of doxorubicin, with buyers ranging from government procurement agencies to private pharmaceutical distributors.

QWhat is the average import order value for doxorubicin from India?

The average import transaction value for doxorubicin from India is , with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.

Buyer Segment Analysis

TransData Nexus Doxorubicin buyer market intelligence

1Buyer Segment Analysis

The buyer landscape for Doxorubicin imported from India encompasses several key segments:

TransData Nexus Research · Government and regulatory sourcesMar 2026

Country-Specific Import Regulations

TransData Nexus Doxorubicin buyer market intelligence

1Country-Specific Import Regulations

United States

1. Regulatory Authority: U.S. Food and Drug Administration (FDA).

3. Estimated Timeline for Registration: The FDA review process typically takes 10 months for standard applications, though priority reviews can be expedited to 6 months.

4. Import Tariff/Duty for HS 30049046: Pharmaceutical products under this HS code are generally duty-free in the United States.

Canada

1. Regulatory Authority: Health Canada.

2. Import Registration Process: Importers must obtain a Drug Identification Number (DIN) by submitting a New Drug Submission (NDS) or an Abbreviated New Drug Submission (ANDS) for generics.

3. Estimated Timeline for Registration: The review process can take up to 300 days for standard submissions.

4. Import Tariff/Duty for HS 30049046: Pharmaceutical products under this HS code are typically duty-free in Canada.

Mozambique

1. Regulatory Authority: Pharmacy Department of the Ministry of Health.

2. Import Registration Process: Importers must register pharmaceutical products by submitting a dossier that includes quality, safety, and efficacy data.

3. Estimated Timeline for Registration: The registration process can take approximately 12 months.

4. Import Tariff/Duty for HS 30049046: Pharmaceutical products may be subject to import duties; specific rates should be confirmed with local customs authorities.

Vietnam

1. Regulatory Authority: Drug Administration of Vietnam (DAV).

Demand Drivers & Market Opportunity

TransData Nexus Doxorubicin buyer market intelligence

1Demand Drivers & Market Opportunity

TransData Nexus Research · Government and regulatory sourcesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Doxorubicin

Doxorubicin

Who Buys Doxorubicin from India — 899 Importers Behind a $67.3M Market

Top Doxorubicin Importers — Ranked by Import Value

Top Doxorubicin Buyers & Importers

Related Analysis

Need Details?

Market Analysis: Top Importing Countries & Importers

Which companies are buying Doxorubicin — and from which countries?

Doxorubicin — Buyer Countries to Key Importers

Market Analysis: Top Importing Countries & Their Importers

1United States

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Common Questions — Doxorubicin Buyers & Importers

QWho is the largest doxorubicin buyer importing from India?

QHow many companies buy doxorubicin from India?

QWhich countries import the most doxorubicin from India?

QWhat is the average import order value for doxorubicin from India?

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

2Canada

3Mozambique

4Vietnam

5Saudi Arabia

Analysis Methodology